IL-8 Is Upregulated in the Tissue-Derived EVs of Odontogenic Keratocysts

Liu, Jian-Feng; Zhang, Chen-Xi; Li, Rui-Fang; Man, Qi-Wen

doi:https://doi.org/10.1155/2022/9453270

BioMed Research International

On this page

Abstract Background Materials and Methods Results Discussion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 9453270 | https://doi.org/10.1155/2022/9453270

IL-8 Is Upregulated in the Tissue-Derived EVs of Odontogenic Keratocysts

Jian-Feng Liu,¹Chen-Xi Zhang,¹Rui-Fang Li,¹and Qi-Wen Man^1,2

Academic Editor: Krzysztof Siemianowicz

Received17 May 2022

Accepted30 Jun 2022

Published30 Jul 2022

Abstract

Background. Interleukin 8 (IL-8) is a chemotactic cytokine released by various cells including leukocytes, endothelial cells, and epithelial cells. IL-8 has multiple functions in inflammation, tumour invasion, or angiogenesis. Human odontogenic cystic lesions are chronic and frequently inflamed. Tissue-derived extracellular vesicles (Ti-EVs) are widely present in various tissues and could more accurately reflect the characteristics of the primary tissue. However, the involvement of IL-8 in Ti-EVs of human odontogenic lesions is still unclear. This study aimed to explore the expression of IL-8 in Ti-EVs of human odontogenic lesions and the potential roles of Ti-EVs that carried IL-8. Methods. Fresh tissue samples of dentigerous cyst (DC, ) and odontogenic keratocyst (OKC, ) were collected for Ti-EVs isolation. Ti-EVs were characterised by transmission electron microscopy and nano-flow cytometry analysis. The cytokine profile of Ti-EVs was explored by cytokine antibody array. The IL-8 expression was examined by immunochemical staining in tissue of odontogenic lesions (DC, n =12; OKC, n =28). Antioxidants (N-acetyl-L-cysteine and diphenyleneiodonium) were employed to treat HaCaT cells, and the expression of IL-8 was detected by enzyme-linked immunosorbent assay. The gene expression of MMP9 was explored by quantitative real-time polymerase chain reaction in co-culture system of fibroblasts of OKC with Ti-EVs. Results. Compared with DC, the expression of IL-8 in Ti-EVs and fixed tissue specimens of OKC was markedly upregulated. The antioxidants decreased the expression level of IL-8 protein in the supernatant of HaCaT cells. The Ti-EVs treatment (10 μg/ml) of fibroblasts significantly induced the MMP9 mRNA expressions in OKC fibroblasts. Conclusions. IL-8 was upregulated in Ti-EVs of OKC and might be involved in the tissue destruction of OKC.

1. Background

Odontogenic keratocysts (OKCs) are common jaw cysts, which were characterised by local invasiveness and high recurrence potential [1]. Genetic study revealed that a proportion of OKC lesions is related with a mutation or inactivation of the PTCH1 gene [2]. The bacterial products are commonly present in the jaw cystic lesions; thus, various cytokines and chemokines are widely distributed in the microenvironment of the odontogenic lesions [3]. In addition, during the progression of OKCs, degradation of supporting tissues and jaw bone can be observed accompanied by the alternative expression of cytokines, matrix metalloproteinases (MMPs), interleukins (ILs), and chemokines [4]. Accumulating studies showed the crucial roles of MMPs in regulating homeostasis, degradation, and reconstruction of the extracellular matrix (ECM) in pathologic and physiological conditions [4, 5]. The aberrant level of the cytokines or chemokines could break the balance between the homeostasis of the immune microenvironment and bone metabolism. However, the regulatory roles of cytokines in the enlargement of OKCs are still unexplored.

Extracellular vesicles (EVs) are lipid-bilayer membrane structures secreted by most cell types [6]. EVs act as messengers via the horizontal transfer of lipids, proteins, and nucleic acids; they influence various pathophysiological processes in parent and recipient cells [6]. Previous studies focused on the cell-line derived or body fluid-derived EVs, which were relatively easy to isolate [6–8]. However, the cell-line derived EVs are not representative of the disease study, and the body fluid-derived EVs are enriched in the contaminations, such as immunoglobulins and blood cell-derived substances [9]. Compared with the body fluid-derived EVs or cell line-derived EVs, tissue-derived EVs had the advantage of tissue specificity and accurate reflection of tissue microenvironment [9]. However, the tissue-derived EVs had not been illuminated in odontogenic tissues. Cytokines are soluble proteins that mediate cell–cell communication in the body [10]. Cytokines are generally thought to be released and functioned as soluble molecules [10]. However, we found that bioactive cytokines, especially specific cytokines, could be packaged into the EVs. In addition, the cytokine profile of the tissue-derived EVs in odontogenic cysts remains unknown.

Interleukin-8 (IL-8) is a chemoattractant cytokine produced by various cells including leukocytes, endothelial cells, and epithelial cells [11]. Report showed that endothelial cells store IL-8 in their storage vesicles named the Weibel–Palade bodies [12]. Originally, IL-8 was identified as neutrophil chemoattractant via binding to the receptors CXCR1/2 [13]. In addition, IL-8 was reported to promote integrin β3 upregulation and the invasion of hepatocellular carcinoma cells through activation of the PI3K/Akt pathway [14]. Oral cavity hosts a bacterial environment, which was related with physiological barrier, caries, and bad oral breath habit [15]. In odontogenic lesions, IL-8 had been proven to be highly expressed in ameloblastoma epithelial cells and irreversible pulpitis [16, 17]. We isolated Ti-EVs of odontogenic lesions and compared the cytokine profiles from DC and OKC patients. We showed that IL-8 was predominantly enriched in OKC Ti-EVs, and the level of IL-8 was closely related with reactive oxygen species (ROS) production. This study initially investigated the cytokine profile of Ti-EVs of odontogenic lesions and implied that Ti-EVs containing IL-8 might be related with the progression of OKC, which might be a potential target for OKC treatment.

2. Materials and Methods

2.1. Single-Cell Suspension from OKC and DC Tissue

The tissue samples of odontogenic keratocyst (OKC) and dentigerous cyst (DC) were collected from the Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University. The tissue was rinsed with phosphate-buffered saline (PBS) in an effort to remove blood clots and impurities. The weight of the collected tissue was measured using milligram balance. The tissue samples were gently washed twice by PBS and cut into pieces () using scissors. Enzymes are used at the following concentrations: collagenase D (1 mg/ml, Sigma-Aldrich, Germany) and DNase I (40 U/ml, Sigma-Aldrich, Germany). Based on the weight of the tissue, the appropriate volume of enzymes was thawed. This step allows EVs to be released from the tissue, where they are entrapped. Then, the mixture was placed at 37°C for 1 hour in the mechanical horizontal rotators. A 0.70 μm pore size filter was applied to remove the largest elements among the suspension.

2.2. Ti-EVs Isolation

The supernatant was centrifuged at for 30 min to remove large vesicles using the Centrifuge 5810R (Eppendorf, Germany), followed by ultracentrifugation at for 70 min (Optima XE, Beckman Coulter, USA). The Ti-EVs pellet were resuspended in 100 μl of Phosphate-Buffered Saline (PBS, Gibco, USA) and ultracentrifuged at for 70 min and transferred to Eppendorf tubes. The collected Ti-EVs were stored at −80°C for further examination.

2.3. Transmission Electron Microscopy (TEM)

TEM was performed at the Servicebio, Wuhan, China. Ti-EVs were mounted onto copper-coated TEM grids for detection. The grids were stained with 1% uranyl acetate, and the Ti-EVs were captured using the Hitachi HT7700 transmission electron microscope (Hitachi, Ltd., Tokyo, Japan).

2.4. Nano-flow Cytometry

An amount of 1 μl antibodies was incubated with 10 μl Ti-EVs. The following antibodies were used: PE-conjugated CD63 (1 : 10, 353003; BioLegend). Samples were incubated with the above antibodies at 4°C for 1 hour. Data were collected with an A60-Micro Plus nanoscale flow cytometer (Apogee Flow Systems Inc., Northwood, UK) and analysed using FlowJo software (VX.0.7) for nano-flow cytometry analysis.

2.5. Cytokine Antibody Array

For cytokine antibody array, equal quality of Ti-EVs (50 μg protein, DC- and OKC-derived Ti-EVs) were loaded for analysis. Following the manufacturer’s protocols, cytokines and chemokines were detected using Bio-Plex Pro Human Cytokine Screening 40-plex Panel using Bio-Plex MAGPIX System (Bio-Rad) (Wayen Biotechnologies (Shanghai), Inc.).

2.6. Enzyme-linked Immunosorbent Assay (ELISA)

Standard IL-8 proteins were prepared using Human Interleukin 8 (IL-8) ELISA Kit (CUSABIO, Wuhan, China). Standard IL-8 protein (2000, 1000, 500, 250, 125, 62.5, and 0 pg/ml) or Ti-EV samples of 100 μl (50 μg) were added to each well, mixed gently, and incubated at 37°C for 1 hour. After the liquid is removed, 100 μl of biotin-antibody (1x) was added to each well and incubated for 1 hour at 37°C. Then, the liquid was discarded and washed by 200 μl washing solution per well. Horseradish peroxidase (HRP)-Avidin (1x) working solution 100 μl was added to each well and incubated at 37°C for 1 hour. After washing, 90 μl of substrate solution was added to each well in sequence, and color was developed at 37°C for 15–30 minutes away from light. Finally, 50 μl stop solution was added to each well in sequence to stop the reaction. Within 5 minutes after the termination of the reaction, the optical density (OD) of each well was measured in sequence at 450 nm with a microplate reader (Bio-Tek, USA).

2.7. Cell Treatments

HaCaT cells were seeded at a starting density of cells/dish in growth medium (DMEM with high glucose, Hyclone) supplemented with 10% FBS in 6 cm dishes. The cells were then allowed to adhere to the wells in the incubator prior to treatments. Cells, which were typically ~80%–90% confluent, were treated with 1 mM NAC (the scavenger of ROS, Beyotime, China) or 10 μM diphenyleneiodonium chloride (ROS inhibitor, Beyotime, China) for 6 hours. Controls and the treated supernatant samples were collected and tested for IL-8 levels. In addition, HaCaT cells were treated with thapsigargin (2 μM, Selleck, USA) or the NF-κB inhibitor (BAY 11-7082, 2 μM, Selleck, USA). Thapsigargin is a noncompetitive inhibitor of the sarco/endoplasmic reticulum Ca²⁺ ATPase, which could raise cytosolic (intracellular) calcium concentration by blocking the ability of the cell to pump calcium into the sarcoplasmic and endoplasmic reticula.

2.8. [Ca²⁺] Measurement Assay

The intracellular Ca²⁺ concentration in the cyst fluid or supernatant of HaCaT cells was detected by a calcium colorimetric assay kit (Beyotime, China). The HaCaT cells (control group and thapsigargin treated group) were lysed with lysate buffer. Then, 50 μl chromogenic reagent and 50 μl calcium assay buffer were added to the 50 μl cell lysates, followed by the 5 min incubation. Finally, the incubation buffer was loaded in the 96-well microplate reader (Bio-Tek, USA) and then measured with the absorbance at 575 nm.

2.9. Intracellular ROS Level Detection by Dihydroethidium

The intracellular ROS levels of HaCaT cells were assayed using the fluorescence probe dihydroethidium (DHE, Beyotime, China). The HaCaT cells were cultured in slides and treated with the fluorescence probe dihydroethidium. The fluorescence image of the stained cells in the suspension was immediately photographed using fluorescence microscope. The mean intensity of DHE-stained HaCaT cells was calculated by ImageJ 1.52 software.

2.10. Primary Fibroblast Culture and Treatment

The primary fibroblast of odontogenic keratocyst was cultured with tissue culture method. Odontogenic keratocyst tissue was cut into cubes. The cubes were placed on the culture disk for 2 h in an incubator with 5% CO₂ at 37°C humidified atmosphere. Then, culture medium (DMEM, Hyclone+10%FBS, CellMax, China) was added to the culture disk. The culture medium was replaced every three days. At day 7, the spindle-shaped cells were grown in the surroundings of tissue cubes. The Ti-EVs were filtrated with a Millex-GV Filter (0.22 μm, Merck Millipore, USA). After filtration, Ti-EVs (10 μg/ml) were cocultured with fibroblasts or IL-8 neutralisation (Genetex, 10 μg/ml, 2 h, USA) treated fibroblasts.

2.11. Phalloidin Staining of OKC Fibroblast

The original medium was abandoned, and the cells were washed twice with PBS. After the cells were fixed with 4% formaldehyde solution at room temperature, the cells were cleaned with PBS two to three times for 10 min each. Cells were permeated with 0.1%–0.5% Triton X-100 solution for 5 min. The permeating solution was removed and washed with PBS two to three times for 10 min each. The working solution of phalloidin (Abcam, ab235138, UK) was added to cover the cells, and the cells were incubated for 30 min at room temperature away from light. The cells were cleaned three times with PBS for 5 min each. The nuclei were restained according to the DAPI (4',6-diamidino-2-phenylindole) staining solution instructions. The image of the stained cells was immediately photographed using fluorescence microscope.

2.12. Immunohistochemistry Staining

The tissue microarray (TMA) of odontogenic lesions including 11 cases of DC and 30 cases OKC was constructed by Servicebio, Wuhan, China. The TMA of odontogenic lesions was incubated in 65°C for 2 h. The slides of TMA were dewaxed by xylene and dehydrated by graded ethanol. For antigen exposure, the slides were boiled in the electric pressure cooker and cooked to 120°C for 60 seconds. After cooling to the room temperature, the slides were blocked by goat serum. The primary antibody IL-8 (1 : 200, Proteintech, China) was incubated with the slides overnight and followed by HRP-conjugated solutions. Finally, the slides were stained with diaminobenzidine (Zhongshan Golden Bridge Biotechnology Co. Ltd., China) and hematoxylin staining solution (Servicebio, Wuhan, China).

2.13. Immunohistochemical Scoring

The slides of odontogenic lesions were scanned and photographed by a digital pathological slice scanner (3DHISTECH Pannoramic MIDI, Hungary). Aperio Image Scope CS2 scanner (CA, USA) was used for tissue slide scan. Aperio Quantification software (Version 9.1) was applied for the quantification. The epithelial area of the tissue was manually selected for quantification. Then, the formula (1 × the percentage of weakly positive staining) + (2 × the percentage of moderately positive staining) + (3 × the percentage of strongly positive staining) was used for the analysis of the staining scores. The scaled values (-scores) of IL-8 expressions were subsequently converted to the dataset for analysis.

2.14. EVs Uptake Assay

The Ti-EVs were incubated with carboxyfluorescein succinimidyl ester (CFSE, Thermo Fisher, 2 μm) for 20 min under 37°C. The fibroblasts were stained with Dil solution (5 μM, 10 min, Thermo Fisher, D3911, USA). The CFSE-labelled Ti-EVs were cocultured with Dil-stained fibroblasts for 2 h. Then, the supernatant was removed and washed by PBS. The fibroblasts were photographed using a fluorescence microscope (Beckman Coulter, USA).

2.15. Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)

Total RNA was isolated from OKC fibroblasts (control group, Ti-EVs co-cultured group and IL-8 neutralisation (Genetex, 10 μg/ml, USA) plus Ti-EVs cocultured) using TRIzol reagent (Invitrogen, USA), according to manufacturer’s instructions. cDNA was made from total RNA using reverse transcriptase kit (TaKaRa Shuzo, Kyoto, Japan), which was amplified on an Applied Biosystems 7500 real-time PCR system (Foster City, CA, USA). The specific primers (Invitrogen, USA) for MMP9 were 5-TGTACCGCTATGGTTACACTCG-3 (forward) and 5-GGCAGGGACAGTTGCTTCT-3 (reverse). The specific primers for GAPDH were 5-GGAGCGAGATCCCTCCAAAAT-3 (forward) and 5-GGCTGTTGTCATACTTCTCATGG-3 (reverse). The thermal cycling conditions comprised 94°C for 30 sec, 60°C for 1 min, 72°C for 1 min, and a final elongation at 72°C for 10 min, amplifying for 38 cycles. The 2^−ΔΔCT method was used for data analysis.

2.16. Statistics

Statistical analyses were performed with Prism 7.0 software (GraphPad). All results were presented as . Differences of data between two groups were assessed by Mann–Whitney test; one-way ANOVA test or Brown-Forsythe and Welch ANOVA test was used when the data met the normal distribution, and use the Kruskal-Wallis test for data that did not meet the normal distribution. value < 0.05 was considered statistically significant.

3. Results

3.1. Characterisation of Tissue-Derived EVs of DC and OKC

To isolate the tissue-derived EVs, mechanical slicing and collagenase were used to free the EVs within tissue interstitial space. After ultracentrifugation, the tissue-derived EVs were collected and stored. Transmission electron microscopy was performed to explore the characteristics of tissue-derived EVs, and the results showed that membrane vesicles ranging about 100 nm were observed (Figure 1(a)). Nano-flow cytometry was employed to further quantify the CD63 expressions in the surface of tissue-derived EVs, and the results showed that about 30% of tissue-derived EVs were positive for CD63 in the surface (Figure 1(b)).

(a)

(b)

(c)

(d)

3.2. IL-8 Was Highly Expressed in Tissue-Derived EVs and Fixed Tissue Specimens of OKC

A total of 50 μg proteins of Ti-EVs were loaded by cytokine antibody array for the cytokine antibody array. Among the 27 types of cytokines tested, IL-8, RANTES, and FGF were at high concentrations (Figure 1(c)). Ti-EVs from OKC samples () showed significantly higher level of IL-8 than the Ti-EVs of DCs () (Figure 1(d)). To explore the IL-8 expression in tissues, tissue microarray, including DCs and OKCs, was employed for IL-8 evaluation. The results also showed that IL-8 was slightly upregulated in the epithelial cells of OKC () compared with DC () (Figures 2(a) and 2(b)).

(a)

(b)

(c)

(d)

(e)

Figure 2

IL-8 expression in tissues of odontogenic lesions and IL-8 secretion is regulated by the NF-κB signaling pathway in HaCaT cells. (a, b) Representative immunohistochemical staining and score of IL-8 in odontogenic lesions including dentigerous cyst () and odontogenic keratocyst (). (c) The calcium level within the cyst fluid of odontogenic keratocyst () was calculated. (d) Thapsigargin (2 μM) significantly upregulated the intracellular calcium level within HaCaT cells in 90 seconds. (e) Thapsigargin significantly upregulated the protein level of IL-8 in HaCaT cells and partially reduced by NF-κB inhibitor (BAY 11-7082, 2 μM) in 6 h.

We collected the cyst fluid of OKC and tested for the Ca²⁺ concentration to evaluate the Ca²⁺ concentration within cyst fluid. The result showed that the Ca²⁺ concentration of cyst fluid of OKC was about 1.2 mmol/l (Figure 2(c)). In HaCaT cells, TG (thapsigargin, 2 μM) treatment significantly upregulated the Ca²⁺ concentration in 90 s (Figure 2(d), ). In addition, the TG treatment (2 μM, 3 h or 6 h) also induced the elevated IL-8 expressions within the supernatant of HaCaT cells in 6 h (Figure 2(d)). In addition, the NF-κB inhibitor (BAY 11-7082) was used to test the potential role of the NF-κB signalling pathway in TG-treated HaCaT cells (Figure 2(e)). The result showed that NF-κB signalling pathway inhibition could lower the IL-8 levels of HaCaT cells although without significance. Higher intracellular level of Ca²⁺ could lead to the ROS production and NF-κB signalling pathway activation. We also evaluated the intracellular ROS levels after TG treatment. We found that after 2 h of treatment with TG, the intracellular ROS was significantly unregulated by H₂O₂ probe (dihydroethidium) (Figures 3(a) and 3(b), ). We also tested two antioxidants for IL-8 expressions. The result showed that adding antioxidants (N-acetyl-L-cysteine, diphenyleneiodonium) could significantly decrease the IL-8 protein level within the supernatant of HaCaT cells (Figure 3(c), and , respectively).

(a)

(b)

(c)

3.3. EVs Containing IL-8 Promote MMP9 Expressions in OKC Fibroblasts

To further evaluate the biological effects of Ti-EVs, primary fibroblasts were cultured from fresh tissue of OKC. The phalloidin staining showed that OKC fibroblasts showed spindle-shaped cells (Figure 4(a)). The EVs uptake assay also revealed that CFSE-labelled EVs could be uptaken by OKC fibroblasts within 2 h (Figure 4(b)). The OKC fibroblasts were cocultured with Ti-EVs, and the mRNA level of MMP9 was determined by RT-qPCR. The results showed that the mRNA level of MMP9 was significantly upregulated after Ti-EVs treatment for 12 h; it was partially blocked by IL-8 neutralising antibody without significance (Figure 4(c)). This result showed that Ti-EVs carrying IL-8 could induce the MMP9 mRNA upregulation in OKC fibroblasts.

(a)

(b)

(c)

4. Discussion

The findings of this study clearly showed that IL-8 was enriched in Ti-EVs of OKC compared with the cytokines of Ti-EVs of DC. In addition, the calcium influx significantly elevated the ROS level of HaCaT cells and induced the IL-8 levels within the supernatant of cultured epithelial cells. The Ti-EVs of OKC significantly upregulated the mRNA level of MMP9 in OKC fibroblasts. These results initially showed the cytokine profile of Ti-EVs of OKC and implied the potential role of Ti-EVs for supporting bone resorption.

Tissue-derived EVs have several characteristics compared with cell-line derived or body fluid-derived EVs [9, 18]. EVs in body fluids are heterogeneous, originating from different cellular origins and from diverse sources [19, 20]. Tissue-derived EVs could reflect the characteristics of specific tissues and lowered the contamination of plasma proteins or immune globulin, which were widely present in the serum or saliva [18, 19]. Until now, no studies revealed the cytokine profiling of tissue-derived EVs in odontogenic lesions. Herein, we employed the enzyme digestion method to isolate the tissue-derived EVs and analysed the cytokine profile of odontogenic lesions.

IL-8 had been previously determined in odontogenic lesions [16, 17, 21, 22]. Compared with healthy dental pulps, inflamed pulps present higher amounts of IL-1β and IL-8 [17]. In ameloblastoma, coculture of ameloblastoma cells and bone marrow stromal cells significantly upregulate the expression of IL-8, which was related with the bone resorption of ameloblastoma [16]. Using tissue culture model, the IL-8 was detected in radicular cyst and odontogenic keratocyst [21]. In the test of aspirate from jaw cysts, the study also found a significant elevation of IL-8 in OKC compared with ameloblastoma and dentigerous cyst () [22]. In the present study, we use immunohistochemistry staining method, showing that IL-8 was mainly expressed in the epithelium of odontogenic lesions. This finding implies that the epithelial cells might be the main cellular origins of IL-8.

Calcium is a vital mineral, which is crucial for hard tooth enamel formation and bone health [23]. In the serum, the concentration of free ionised calcium was 1.15 mmol/l to 1.29 mmol/l [24]. Similar to the serum-ionised calcium levels, the cyst fluid level of ionised calcium (~1.2 mmol/l) was similar to the level of serum-ionised calcium levels. This finding was in accordance with fluid exchange between cyst fluid and serum. The tissue transient calcium level of odontogenic cysts is still unexplored due to the lack of animal model and instantaneous detection of calcium. The bone resorption process might result in the liberation of calcium and other mineral elements. However, in jaw cyst lesions, the bone resorption rate is very low to induce the significant elevations of calcium in the cyst fluid or tissue. In addition, several pathways can lower the calcium levels including urinary excretion or regulation by calcium sensing receptors.

ROS is the by-product of oxygen metabolism, and ROS plays vital roles in various diseases [25]. As a host defence mechanism against bacterial pathogens, the generation of ROS performed by NADPH oxidase is essential in phagocytic infiltration-related diseases [25, 26]. A study demonstrated that thapsigargin (TG) induces depletion of Ca²⁺ stores, elevating [Ca²⁺]i [27]. In this study, we employed TG to induce the calcium influx and the ROS levels. Odontogenic cystic lesions are frequently inflamed and induced by the bacterial pathogens. A high concentration of ROS and long-term exposure to ROS could lead to cellular damage [26, 28]. Nuclear factor κ-light-chain-enhancer of activated B cell (NF-κB) activation and cellular death are important mechanisms of ROS-mediated exacerbating inflammation [29]. A previous study illustrated that iNOS was overexpressed in OKCs when compared with DCs and radicular cyst, suggesting that iNOS may contribute to the aggressive behaviour of OKC [30]. This finding showed that ROS may play vital roles in inflammatory and developmental cyst lesions. In periapical granulomas, iNOS-positive cells might play a critical role in the activation of macrophages through the induction of NO and might modulate the degree of inflammation [31]. In apical periodontitis, positive correlation of the levels of IL-8 and NO suggests an involvement of neutrophil-derived NO in the pathogenesis of apical periodontitis [21]. In A549 cells, treatment of A549 cells with antioxidants decreased ROS production and expression of IL-8 mRNA [32]. Under hypoxic condition, normal human nasal epithelium cells could translocate HMGB1 into the extracellular area, depending on ROS production and involved in the upregulation of IL-8 [33]. Similar to a previous study, we found that antioxidants (ROS inhibitors) could significantly decrease the IL-8 levels within supernatant of HaCaT cells.

In tumour tissue, tumour-associated fibroblasts play a crucial role in tumour microenvironment and are also the most important cell type [34]. In odontogenic keratocysts, fibroblasts are also the dominant cell type in many characteristics similar to those of tumours, leading to the absorption and regeneration of bone tissue [35]. Tumour cells and fibroblasts communicate with each other, including autocrine and paracrine factors, including IL-8, resulting in the upregulation of MMP2 and MMP9 degradable extracellular matrix (ECM) components that trigger tumour invasion [36]. In trophoblast cell, the study also revealed that IL-8 could bind to CXCR1 and CXCR2, resulting in higher level of MMPs and integrins [37]. However, Ti-EVs stimulated fibroblasts showed significantly higher elevation of MMP9 (about four folds) than the results of trophoblast cell. The combined effects of various cytokines (RANTES, FGF, and MCP-1) and unexplored proteins might explain the remarkable elevations of MMP9.

However, this study has some limitations. Firstly, although EVs containing IL-8 have biological effects, whether the IL-8 was located in the surface or the inside of EVs is still unexplored. Second, a relatively small sample size was employed to confirm the IL-8 expressions in the Ti-EVs of OKC and DC.

In conclusion, we initially isolated tissue-derived EVs of odontogenic cystic lesions, mapped the cytokine profile of OKC, and explored the regulatory role of ROS in IL-8 production.

Data Availability

All data generated or analysed during this study are included in this published article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Jian-Feng Liu, Chen-Xi Zhang, Rui-Fang Li and Qi-Wen Man contributed to this work. Jian-Feng Liu and Chen-Xi Zhang engaged in the design of this study and performed the experiments, Rui-Fang Li and Qi-Wen Man contributed to the data analysis and approved the submitted version. Jian-Feng Liu and Chen-Xi Zhang drafted the manuscript. All authors have read and approved the final manuscript. Jian-Feng Liu and Chen-Xi Zhang contributed equally to this work.

Acknowledgments

This research was supported by the National Natural Science Foundation of China (82001066) to Qi-Wen Man.

References

R. A. Mendes, J. F. C. Carvalho, and I. van der Waal, “Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features,” Oral Oncology, vol. 46, no. 4, pp. 219–225, 2010.
View at: Publisher Site | Google Scholar
D. C. Barreto, R. S. Gomez, A. E. Bale, W. L. Boson, and L. De Marco, “PTCH gene mutations in odontogenic keratocysts,” Journal of Dental Research, vol. 79, no. 6, pp. 1418–1422, 2000.
View at: Publisher Site | Google Scholar
I. A. Iatrou, N. Legakis, E. Ioannidou, and A. Patrikiou, “Anaerobic bacteria in jaw cysts,” The British Journal of Oral & Maxillofacial Surgery, vol. 26, no. 1, pp. 62–69, 1988.
View at: Publisher Site | Google Scholar
K. Kuźniarz, D. Luchowska-Kocot, T. Tomaszewski, and J. Kurzepa, “Role of matrix metalloproteinases and their tissue inhibitors in the pathological mechanisms underlying maxillofacial cystic lesions,” Biomed Rep., vol. 15, no. 2, p. 65, 2021.
View at: Publisher Site | Google Scholar
S. Quintero-Fabián, R. Arreola, E. Becerril-Villanueva et al., “Role of matrix metalloproteinases in angiogenesis and cancer,” Frontiers in Oncology, vol. 9, p. 1370, 2019.
View at: Publisher Site | Google Scholar
M. Colombo, G. Raposo, and C. Théry, “Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles,” Annual Review of Cell and Developmental Biology, vol. 30, no. 1, pp. 255–289, 2014.
View at: Publisher Site | Google Scholar
E. M. Guerreiro, R. Øvstebø, B. Thiede, D. E. Costea, T. M. Søland, and G. H. Kanli, “Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics,” PLoS One, vol. 15, no. 9, article e0238591, 2020.
View at: Publisher Site | Google Scholar
S. Boukouris and S. Mathivanan, “Exosomes in bodily fluids are a highly stable resource of disease biomarkers,” Proteomics. Clinical Applications, vol. 9, no. 3-4, pp. 358–367, 2015.
View at: Publisher Site | Google Scholar
S. R. Li, Q. W. Man, X. Gao et al., “Tissue-derived extracellular vesicles in cancers and non-cancer diseases: present and future,” J Extracell Vesicles., vol. 10, no. 14, article e12175, 2021.
View at: Publisher Site | Google Scholar
D. J. Propper and F. R. Balkwill, “Harnessing cytokines and chemokines for cancer therapy,” Nature Reviews. Clinical Oncology, vol. 19, no. 4, pp. 237–253, 2022.
View at: Publisher Site | Google Scholar
M. Bickel, “The role of interleukin-8 in inflammation and mechanisms of regulation,” Journal of Periodontology, vol. 64, 5 Suppl, pp. 456–460, 1993.
View at: Google Scholar
J. O. Utgaard, F. L. Jahnsen, A. Bakka, P. Brandtzaeg, and G. Haraldsen, “Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells,” The Journal of Experimental Medicine, vol. 188, no. 9, pp. 1751–1756, 1998.
View at: Publisher Site | Google Scholar
M. Baggiolini, A. Walz, and S. L. Kunkel, “Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils,” The Journal of Clinical Investigation, vol. 84, no. 4, pp. 1045–1049, 1989.
View at: Publisher Site | Google Scholar
F. Sun, J. Wang, Q. Sun et al., “Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma,” Journal of Experimental & Clinical Cancer Research, vol. 38, no. 1, p. 449, 2019.
View at: Publisher Site | Google Scholar
L. Sedghi, V. DiMassa, A. Harrington, S. V. Lynch, and Y. L. Kapila, “The oral microbiome: role of key organisms and complex networks in oral health and disease,” Periodontology 2000, vol. 87, no. 1, pp. 107–131, 2021.
View at: Publisher Site | Google Scholar
X. Liu, Z. Chen, T. Lan, P. Liang, and Q. Tao, “Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma,” International Journal of Molecular Medicine, vol. 43, no. 6, pp. 2329–2340, 2019.
View at: Publisher Site | Google Scholar
A. C. Silva, M. R. Faria, A. Fontes, M. S. Campos, and B. N. Cavalcanti, “Interleukin-1 beta and interleukin-8 in healthy and inflamed dental pulps,” Journal of Applied Oral Science, vol. 17, no. 5, pp. 527–532, 2009.
View at: Publisher Site | Google Scholar
B. Qin, X. M. Hu, Z. H. Su, X. B. Zeng, H. Y. Ma, and K. Xiong, “Tissue-derived extracellular vesicles: research progress from isolation to application,” Pathology, Research and Practice, vol. 226, p. 153604, 2021.
View at: Publisher Site | Google Scholar
D. Osti, M. Del Bene, G. Rappa et al., “Clinical significance of extracellular vesicles in plasma from glioblastoma patients,” Clinical Cancer Research, vol. 25, no. 1, pp. 266–276, 2019.
View at: Publisher Site | Google Scholar
G. Chiabotto, C. Gai, M. C. Deregibus, and G. Camussi, “Salivary extracellular vesicle-associated exRNA as cancer biomarker,” Cancers (Basel)., vol. 11, no. 7, p. 891, 2019.
View at: Publisher Site | Google Scholar
H. Shimauchi, S. Takayama, M. Narikawa-Kiji, Y. Shimabukuro, and H. Okada, “Production of interleukin-8 and nitric oxide in human periapical lesions,” Journal of Endodontia, vol. 27, no. 12, pp. 749–752, 2001.
View at: Publisher Site | Google Scholar
A. Kolokythas, M. Karas, T. Sarna, W. Flick, and M. Miloro, “Does cytokine profiling of aspirate from jaw cysts and tumors have a role in diagnosis?” Journal of Oral and Maxillofacial Surgery, vol. 70, no. 5, pp. 1070–1080, 2012.
View at: Publisher Site | Google Scholar
R. S. Lacruz, S. Habelitz, J. T. Wright, and M. L. Paine, “Dental enamel formation and implications for oral health and disease,” Physiological Reviews, vol. 97, no. 3, pp. 939–993, 2017.
View at: Publisher Site | Google Scholar
W. G. Robertson, R. W. Marshall, and M. Walser, “Calcium measurements in serum and plasma--total and ionized,” CRC Critical Reviews in Clinical Laboratory Sciences, vol. 11, no. 3, pp. 271–304, 1979.
View at: Publisher Site | Google Scholar
H. Van Acker and T. Coenye, “The role of reactive oxygen species in antibiotic-mediated killing of bacteria,” Trends in Microbiology, vol. 25, no. 6, pp. 456–466, 2017.
View at: Publisher Site | Google Scholar
W. Ying, “NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences,” Antioxidants & Redox Signaling, vol. 10, no. 2, pp. 179–206, 2008.
View at: Publisher Site | Google Scholar
K. T. Jones and G. R. Sharpe, “Thapsigargin raises intracellular free calcium levels in human keratinocytes and inhibits the coordinated expression of differentiation markers,” Experimental Cell Research, vol. 210, no. 1, pp. 71–76, 1994.
View at: Publisher Site | Google Scholar
G. E. Villalpando-Rodriguez and S. B. Gibson, “Reactive oxygen species (ROS) regulates different types of cell death by acting as a rheostat,” Oxidative Medicine and Cellular Longevity, vol. 2021, 9912417 pages, 2021.
View at: Publisher Site | Google Scholar
M. J. Morgan and Z. G. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, no. 1, pp. 103–115, 2011.
View at: Publisher Site | Google Scholar
P. Swetha, K. Ramesh, N. Madhavan, V. Veeravarmal, and A. Sameera, “Expression of inducible nitric oxide synthase in the epithelial linings of odontogenic keratocyst, dentigerous cyst and radicular cyst: a pathological insight,” Annals of Medical and Health Sciences Research, vol. 4, no. 4, pp. 583–589, 2014.
View at: Publisher Site | Google Scholar
H. Kabashima, K. Nagata, K. Maeda, and T. Iijima, “Interferon-gamma-producing cells and inducible nitric oxide synthase-producing cells in periapical granulomas,” Journal of Oral Pathology & Medicine, vol. 27, no. 3, pp. 95–100, 1998.
View at: Publisher Site | Google Scholar
S. F. Ye, Y. H. Wu, Z. Q. Hou, and Q. Q. Zhang, “ROS and NF-κB are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes,” Biochemical and Biophysical Research Communications, vol. 379, no. 2, pp. 643–648, 2009.
View at: Publisher Site | Google Scholar
H. J. Min, J. H. Kim, J. E. Yoo et al., “ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition,” Mucosal Immunology, vol. 10, no. 3, pp. 685–694, 2017.
View at: Publisher Site | Google Scholar
H. Li, X. Fan, and J. Houghton, “Tumor microenvironment: the role of the tumor stroma in cancer,” Journal of Cellular Biochemistry, vol. 101, no. 4, pp. 805–815, 2007.
View at: Publisher Site | Google Scholar
M. Vered, I. Shohat, A. Buchner, and D. Dayan, “Myofibroblasts in stroma of odontogenic cysts and tumors can contribute to variations in the biological behavior of lesions,” Oral Oncology, vol. 41, no. 10, pp. 1028–1033, 2005.
View at: Publisher Site | Google Scholar
M. Luca, S. Huang, J. E. Gershenwald, R. K. Singh, R. Reich, and M. Bar-Eli, “Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis,” The American Journal of Pathology, vol. 151, no. 4, pp. 1105–1113, 1997.
View at: Google Scholar
M. Jovanović, I. Stefanoska, L. Radojcić, and L. Vićovac, “Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1,” Reproduction, vol. 139, no. 4, pp. 789–798, 2010.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Jian-Feng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

322

Downloads

703

Citations

BioMed Research International

IL-8 Is Upregulated in the Tissue-Derived EVs of Odontogenic Keratocysts

Abstract

1. Background

2. Materials and Methods

2.1. Single-Cell Suspension from OKC and DC Tissue

2.2. Ti-EVs Isolation

2.3. Transmission Electron Microscopy (TEM)

2.4. Nano-flow Cytometry

2.5. Cytokine Antibody Array

2.6. Enzyme-linked Immunosorbent Assay (ELISA)

2.7. Cell Treatments

2.8. [Ca2+] Measurement Assay

2.9. Intracellular ROS Level Detection by Dihydroethidium

2.10. Primary Fibroblast Culture and Treatment

2.11. Phalloidin Staining of OKC Fibroblast

2.12. Immunohistochemistry Staining

2.13. Immunohistochemical Scoring

2.14. EVs Uptake Assay

2.15. Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)

2.16. Statistics

3. Results

3.1. Characterisation of Tissue-Derived EVs of DC and OKC

3.2. IL-8 Was Highly Expressed in Tissue-Derived EVs and Fixed Tissue Specimens of OKC

3.3. EVs Containing IL-8 Promote MMP9 Expressions in OKC Fibroblasts

4. Discussion

Data Availability

Conflicts of Interest

Authors’ Contributions

Acknowledgments

References

Copyright

2.8. [Ca²⁺] Measurement Assay